Pitt research helps explain how Ritalin sharpens attention
Even half a century after a drug comes on the market, scientists can still learn new things about how it works. New research from University of Pittsburgh neuroscientists provides a rare look at how Ritalin affects activity in the brains of animals, providing a deeper understanding of how groups of brain cells govern attention and…
Read MoreAutism, ADHD and school absence are risk factors for self-harm, according to new study
Research led by King’s College London and South London and Maudsley NHS Foundation Trust has analyzed factors associated with self-harm in over 111,000 adolescents aged 11-17 years old. Published in BMC Medicine the study found that the risk for self-harm presenting to hospital emergency departments was nearly three times higher for boys with autism spectrum…
Read MoreMental Health Startup Cerebral To Stop ADHD Prescriptions For New Patients
The mental health startup Cerebral said it would stop prescribing controlled substances to treat ADHD for new patients on Wednesday, a week after an ex-executive filed a lawsuit alleging he was fired in retaliation for speaking up about unethical business practices, including the company’s practice of overprescribing stimulants in order to retain patients.
Read MoreFDA Approves Xelstrym to Treat ADHD
Key takeaways: In March 2022, Xelstrym (dextroamphetamine) became the first FDA-approved amphetamine patch to treat ADHD in adults and children at least 6 years of age. Common side effects of Xelstrym include a smaller appetite, trouble sleeping, and headache. More serious side effects include dependence, heart problems, and serotonin syndrome. Xelstrym will probably be available…
Read MoreFDA OKs New Nonstimulant Option for Adult ADHD
The FDA expanded the approval of viloxazine extended-release capsules (Qelbree) to include adults with ADHD, Supernus Pharmaceuticals announced. Now indicated for adults ages 18 and older, viloxazine is the first nonstimulant ADHD option for adults in 20 years. The agent was initially approved in April 2021 for children ages of 6 to 17.
Read MoreBreaking Down the Stigma Surrounding ADHD
Imagine being unable to read a paragraph or follow a conversation without your mind wandering. Losing track of time is something you’re known for among family and friends, and you can’t seem to meet deadlines despite your best efforts. Your tendency to speak without thinking sometimes bruises feelings. You may occasionally interrupt people so you…
Read MoreAdherence to ADHD Meds May Lower Unemployment Risk
Adherence to medication for attention-deficit/hyperactivity disorder (ADHD) is linked to a significantly lower the risk for unemployment, particularly among women, new research suggests.
Read MoreA clash over online Adderall prescriptions is raising new questions about telehealth
Online pharmacy startups have pledged to make it faster and easier than ever to get needed medications. But a high-profile series of setbacks is calling into question whether the realities of drug prescribing are clashing with those promises.
Read MoreADHD and Narcissistic Personality Disorder: How Similar Are They?
ADHD and narcissistic personality may share some behavioral similarities, but they’re different conditions. Attention deficit hyperactivity disorder (ADHD) and narcissistic personality disorder (NPD) are different mental health diagnoses yet in some instances, behaviors may look similar. The cause of these behaviors, though, is very different in each condition.
Read MoreADHD and Hypersexuality: What’s the Connection?
Not all people living with ADHD experience hypersexuality. But for those who do, it’s still possible to have a healthy sex life.
Read MoreTikTok sparks woman’s ADHD diagnosis at age 34. How social media is changing the conversation
TikTok accounts are now shining a light on symptoms of ADHD.
Read MoreEEOC: Employer rescinded job offer based on ADHD meds, violated ADA
Dive Brief: A Texas location of International Paper Co. violated the Americans with Disabilities Act when it revoked a conditional job offer to an applicant diagnosed with ADHD because the applicant failed a drug test, the U.S. Equal Employment Opportunity Commission alleged in a lawsuit announced April 11.
Read More